<DOC>
	<DOCNO>NCT02927587</DOCNO>
	<brief_summary>Target-Controlled Infusion ( TCI ) Propofol prove safe agent conscious sedation flexible bronchoscopy ( FB ) .However , target set `` effect-site '' concentration ( Cet ) propofol still unclear elderly population .The aim study compare two induction Cet propofol elderly patient undergo flexible bronchoscopy .</brief_summary>
	<brief_title>Optimal TCI Regimen Sedation Elderly Undergoing Fiberoptic Bronchoscopy</brief_title>
	<detailed_description>BACKGROUND : Bronchoscopy nowadays common widespread technique allow physician proceed diagnostic therapeutic intervention . The risk procedure low depend mostly health patient . In study consider elderly ( age &gt; 65 year old ) make risk even high . Target-Controlled Infusion ( TCI ) Propofol prove safe agent conscious sedation flexible bronchoscopy ( FB ) due fast onset action rapid recovery time . By virtue age population , number bronchoscopy perform likely increase elderly patient , however , target set `` effect-site '' concentration ( Cet ) propofol still unclear among population . The aim study compare two induction Cet propofol elderly patient undergo flexible bronchoscopy . METHODS : Seventy patient randomly divide 2 group . All patient American Society Anesthesiologists ( ASA ) physical status I-III , age 65 year old 45 100 kg weight . The induction Cet target respectively 1 2 ug/ml . Upon reach modify observer 's assessment alertness/sedation ( MOAA/S ) score 0-3 , Cet increase reduced procedure Ce level set maintenance sedation . Induction time , diagnostic procedure well occurrence adverse event apnea , hypotension hypertension , heart rate , oxygen saturation ( SpO2 ) , cardiac event , cough score , frequency adjustment drug dos record . The patient monitor procedure periodic blood pressure check , respiratory rate , continuous electrocardiogram monitoring heart oxygen measurement .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<criteria>body mass index &lt; 30 male &lt; 28 female ASA physical status I III severe sleep apnoea syndrome ( apnoeahypopnea index &gt; 40 ) bradycardia hypotension</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>TCI</keyword>
	<keyword>fiberoptic bronchoscopy</keyword>
	<keyword>sedation</keyword>
</DOC>